Literature DB >> 20009888

HOXA10 is overexpressed in human ovarian clear cell adenocarcinoma and correlates with poor survival.

Bin Li1, Hongyan Jin, Yinhua Yu, Chao Gu, Xianrong Zhou, Naiqing Zhao, Youji Feng.   

Abstract

Human homeobox gene (HOX) A10 is a homeobox allotype gene of the HOXA family in the HOX family. Human homeobox gene A10 may play an important role in cancer development. However, the role of HOXA10 in the carcinogenesis of ovarian clear cell adenocarcinoma (OCCA) has not been established. We have evaluated the prognostic significance of HOXA10 expression for human OCCA and the effects of HOXA10 on proliferation, motility, and invasion of OCCA cells. We found that HOXA10 was not expressed in normal ovarian epithelium, ovarian endometrial cysts, and ovarian serous carcinomas, but 20 (68.9%) of the 29 OCCAs were positive for the expression of HOXA10. Human homeobox gene A10 expression was negatively correlated to the 5-year survival of OCCA patients (R = -0.442, P = 0.043). When a HOXA10 expression vector was stably transfected into a human OCCA cell line, ES-2, the proliferation rate of ES-2-HOXA10 was much higher than the vector control, the motility of ES-2-HOXA10 cells was significantly increased compared with the control (P < 0.05), and the invasion of ES-2-HOXA10 cells was also much higher than the vector control (P < 0.01 at 5 hours and 12 hours after scratching). In conclusion, HOXA10 was overexpressed in OCCA and was correlated with poor survival. HOXA10 promotes proliferation, migration, and invasion of OCCA cells. Human homeobox gene A10 could be a promising prognostic marker for OCCA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20009888     DOI: 10.1111/IGC.0b013e3181a83f1d

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  19 in total

1.  The loss of Hoxa5 function causes estrous acyclicity and ovarian epithelial inclusion cysts.

Authors:  Gaëlle Gendronneau; Olivier Boucherat; Josée Aubin; Margot Lemieux; Lucie Jeannotte
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

2.  Integration and bioinformatics analysis of DNA-methylated genes associated with drug resistance in ovarian cancer.

Authors:  Bingbing Yan; Fuqiang Yin; Q I Wang; Wei Zhang; L I Li
Journal:  Oncol Lett       Date:  2016-05-18       Impact factor: 2.967

3.  Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma.

Authors:  Hiroshi Kobayashi; Hitomi Sugimoto; Shunsuke Onishi; Kazutoshi Nakano
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

4.  HOXA10 promotes cell invasion and MMP-3 expression via TGFβ2-mediated activation of the p38 MAPK pathway in pancreatic cancer cells.

Authors:  Xian-Ping Cui; Cheng-Kun Qin; Zhen-Hai Zhang; Zhong-Xue Su; Xin Liu; Shi-Kang Wang; Xing-Song Tian
Journal:  Dig Dis Sci       Date:  2014-01-25       Impact factor: 3.199

5.  Napsin A is a specific marker for ovarian clear cell adenocarcinoma.

Authors:  Yoriko Yamashita; Tetsuro Nagasaka; Aya Naiki-Ito; Shinya Sato; Shugo Suzuki; Shinya Toyokuni; Masafumi Ito; Satoru Takahashi
Journal:  Mod Pathol       Date:  2014-04-11       Impact factor: 7.842

6.  Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype.

Authors:  Jae Yun Lim; Sun Och Yoon; So-Young Seol; Soon Won Hong; Jong Won Kim; Seung Ho Choi; Ju-Seog Lee; Jae Yong Cho
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

Review 7.  The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma.

Authors:  Priya Samuel; David Raul Francisco Carter
Journal:  Mol Diagn Ther       Date:  2017-02       Impact factor: 4.074

8.  A gene expression profile test for the differential diagnosis of ovarian versus endometrial cancers.

Authors:  Anita Lal; Rebecca Panos; Mira Marjanovic; Michael Walker; Eloisa Fuentes; Daniel S Kapp; W David Henner; Ljubomir J Buturovic; Meredith Halks-Miller
Journal:  Oncotarget       Date:  2012-02

9.  HOX genes in ovarian cancer.

Authors:  Zoë L Kelly; Agnieszka Michael; Simon Butler-Manuel; Hardev S Pandha; Richard Gl Morgan
Journal:  J Ovarian Res       Date:  2011-09-09       Impact factor: 4.234

10.  miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10.

Authors:  Yating Chen; Jin Zhang; Huijun Wang; Jiayi Zhao; Cheng Xu; Yingying Du; Xin Luo; Fengyun Zheng; Rui Liu; Hongwei Zhang; Duan Ma
Journal:  BMC Cancer       Date:  2012-03-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.